EP Patent

EP2214482A4 — Prostaglandin analog compositions and methods to treat epithelial-related conditions

Assigned to Lipkin Pamela · Expires 2011-08-24 · 15y expired

What this patent protects

Patent listed against Vyzulta.

Drugs covered by this patent

Patent Metadata

Patent number
EP2214482A4
Jurisdiction
EP
Classification
—
Expires
2011-08-24
Drug substance claim
No
Drug product claim
No
Assignee
Lipkin Pamela
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.